IL15 and neoplasm: We observed significantly higher frequencies of circulating CAR19 + NK cells and lower tumor burden in the bone marrow of animals treated with CAR19/IL-15 NK cells from Opt-Cs compared to those from Sub-Cs (Extended Data Fig. 9b,c and Supplementary Fig. 3a).